• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

PLC Systems Inc.

PLC Systems reports revenue surge in 3rd quarter

November 15, 2013 By Chris Walker Leave a Comment

PLC Systems reports revenue surge in 3rd quarter

PLC Systems (OTC:PLCSF) is cutting down on its losses, thanks in part to strong revenues during the 3rd quarter.

PLC Systems posted losses of $609,000, or -1¢ per share, on sales of $348,000 for the 3 months ended Sept. 30, narrowing losses by 81% and boosting sales 64.2% over the same period last year.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: 2013, PLC Systems Inc., Q3

PLC Systems lands Japanese OK for RenalGuard trial

October 18, 2013 By Chris Walker Leave a Comment

PLC Systems lands Japanese OK for RenalGuard trial

PLC Systems (OTC:PLCSF) won approval from the Japanese Ministry of Health, Labor & Welfare for a clinical trial of its RenalGuard device.

Filed Under: News Well Tagged With: Clinical Trials, Japanese Pharmaceuticals and Medical Devices Agency, PLC Systems Inc.

PLC Systems raises $1.8M through common stock

September 19, 2013 By Arezu Sarvestani Leave a Comment

PLC Systems raises $1.8M through common stock

Medical device maker PLC Systems (PINK:PLCSF) touted a new $1.75 million raise, which the company plans to use to fund its ongoing U.S. pivotal trial for the RenalGuard system.

Filed Under: Funding Roundup, News Well, Replacement Heart Valves Tagged With: PLC Systems Inc.

TAVI: PLC Systems launches RenalGuard trial

September 16, 2013 By Sony Salzman Leave a Comment

TAVI: PLC Systems launches RenalGuard trial

PLC Systems (PINK:PLCSF) said its RenalGuard device was used in a new clinical trial evaluating the device in treating patients with acute kidney failure undergoing transcatheter aortic valve implantation.

Filed Under: News Well Tagged With: Clinical Trials, PLC Systems Inc., Renal

FDA approves 1st Type 2 diabetes drug | Wall Street Beat

April 1, 2013 By Brad Perriello Leave a Comment

MassDevice.com Wall Street Beat

The FDA approved a 1st-of-its-kind treatment for Type 2 diabetes, Johnson & Johnson‘s (NYSE:JNJ) Invokana, with the federal watchdog agency citing it as a pioneer in a new class of diabetes drug.

Filed Under: Funding Roundup, MassDevice Earnings Roundup, News Well, Pharmaceutical, Wall Street Beat Tagged With: 2012, Covidien, Hansen Medical Inc., Johnson and Johnson, PLC Systems Inc., Q4, TriReme Medical Inc.

PLC Systems touts $1M now, $1M later for U.S. RenalGuard trials | Funding Roundup

July 2, 2012 By MassDevice staff Leave a Comment

Funding Roundup

 PLC Systems touts $1M now, $1M later for RenalGuard trials

Filed Under: Funding Roundup, News Well Tagged With: eMerge Health Solutions, IlluminOss Medical Inc., PLC Systems Inc.

World Heart’s 2011 sales go negative | Earnings roundup

April 6, 2012 By MassDevice staff Leave a Comment

MassDevice.com Earnings Roundup

 World Heart’s 2011 sales go negative

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2011, ALR Technologies Inc., AngioDynamics, Angiotech, LED Medical Diagnostics Inc., Mauna Kea Technologies, Opko Health Inc., Organovo, PLC Systems Inc., PositiveID Corp., Q4, Response Biomedical Corp., SOLOS Endoscopy Inc., Vycor Medical Inc., World Heart Corp.

Medtronic wins Canadian approval for brain-stim therapy for epileptics | Regulatory Roundup

March 15, 2012 By MassDevice staff Leave a Comment

MassDevice.com Regulatory Roundup

 Medtronic wins Canadian approval for brain-stim epilepsy therapy

Filed Under: Neuromodulation/Neurostimulation, News Well Tagged With: Acclarent Inc., Alma Lasers, Boston Scientific, Cell>Point, ImThera Medical Inc., Life Recovery Systems, Mauna Kea Technologies, Mevion Medical Systems, PLC Systems Inc., Regulatory Roundup, Simpirica Spine Inc., Somnetics

Will Intuitive Surgical’s stock ever stop? | Wall Street Beat

March 13, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Shares of Intuitive Surgical (NSDQ:ISRG) hit an all-time high yesterday of $529.70 and beat it today, as investors sent the shares to $531.35 apiece this morning.

The spikes followed an upgrade by analysts at Lazard Capital, who raised their price target on the stock to $575 from $525 and reinforced their “buy” rating.

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: BBK Ltd., Capinnova, Devicor Medical Products, DJO Global, Health Care DataWorks, Intuitive Surgical, Neurometrix, NxStage Medical Inc., Orgenesis, PLC Systems Inc., Rockwell Medical Technologies, Solta Medical Inc., Teleflex, Venture Capital/Private Equity, Zoll Medical

FDA clears Smith & Nephew’s Pico pocket NPWT device | Regulatory Roundup

January 6, 2012 By MassDevice staff

Smith & Nephew

Smith & Nephew (NYSE:SNN) won a nod from the FDA for its Pico negative-pressure wound therapy system.

The British orthopedics giant’s wound care division said the FDA cleared the device for use in the home and in hospitals. It’s already on the market in Europe, Canada and Australia, according to a press release.

Filed Under: 510(k), Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA) Tagged With: Avedro Inc., China Kanghui Holdings, Mirador Biomedical Inc., PLC Systems Inc., Regulatory Roundup, Smith & Nephew, Stanmore Implants

Zoll shares spike 23 percent on record 2011 sales and earnings | Earnings Roundup

November 17, 2011 By MassDevice staff Leave a Comment

Zoll logo

Zoll reported record numbers in its top and bottom line for fiscal year 2011, sending its stock up 23 percent overnight.

Zoll shares were trading at $44.35 in the early afternoon today, up from last night’s $35.98 close.

The company’s 2011 sales hit a record high of $523.7 million, 18 percent higher than the $444 million posted last year.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: Bovie Medical Corp., Cardiac Rhythm Management, Cardium Therapeutics, Daxor Corp., Derma Sciences Inc., EDAP TMS SA, Fonar Corp., Imris Inc., InspireMD, Oridion Systems Ltd., Patient Safety Technologies Inc., PLC Systems Inc., Q3, Resuscitation, SANUWAVE Health Inc., Tengion Inc., Zoll Medical

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS